These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24370613)

  • 1. Modulation of strain-specific differences in gene expression by cannabinoid type 2 receptor deficiency.
    Sophocleous A; Sims AH; Idris AI; Ralston SH
    Calcif Tissue Int; 2014 Apr; 94(4):423-32. PubMed ID: 24370613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic background modifies the effects of type 2 cannabinoid receptor deficiency on bone mass and bone turnover.
    Sophocleous A; Idris AI; Ralston SH
    Calcif Tissue Int; 2014 Mar; 94(3):259-68. PubMed ID: 24036631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition.
    Sophocleous A; Marino S; Kabir D; Ralston SH; Idris AI
    Aging Cell; 2017 Oct; 16(5):1051-1061. PubMed ID: 28752643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.
    Canseco-Alba A; Schanz N; Sanabria B; Zhao J; Lin Z; Liu QR; Onaivi ES
    Behav Brain Res; 2019 Mar; 360():286-297. PubMed ID: 30508607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired border zone formation and adverse remodeling after reperfused myocardial infarction in cannabinoid CB2 receptor deficient mice.
    Duerr GD; Heinemann JC; Gestrich C; Heuft T; Klaas T; Keppel K; Roell W; Klein A; Zimmer A; Velten M; Kilic A; Bindila L; Lutz B; Dewald O
    Life Sci; 2015 Oct; 138():8-17. PubMed ID: 25447445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis.
    Sisay S; Pryce G; Jackson SJ; Tanner C; Ross RA; Michael GJ; Selwood DL; Giovannoni G; Baker D
    PLoS One; 2013; 8(10):e76907. PubMed ID: 24130809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The type 2 cannabinoid receptor regulates susceptibility to osteoarthritis in mice.
    Sophocleous A; Börjesson AE; Salter DM; Ralston SH
    Osteoarthritis Cartilage; 2015 Sep; 23(9):1586-94. PubMed ID: 25937028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2014 Mar; 20(1):29-36. PubMed ID: 24722782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2013 Nov; 19(1):357-64. PubMed ID: 24408112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial maladaptation to pressure overload in CB2 receptor-deficient mice.
    Duerr GD; Heinemann JC; Kley J; Eichhorn L; Frede S; Weisheit C; Wehner S; Bindila L; Lutz B; Zimmer A; Dewald O
    J Mol Cell Cardiol; 2019 Aug; 133():86-98. PubMed ID: 31181227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the JNK/c-Jun/Alox5 pathway.
    Liu YJ; Fan HB; Jin Y; Ren CG; Jia XE; Wang L; Chen Y; Dong M; Zhu KY; Dong ZW; Ye BX; Zhong Z; Deng M; Liu TX; Ren R
    J Biol Chem; 2013 May; 288(19):13551-62. PubMed ID: 23539630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice.
    Shapiro L; Wong JC; Escayg A
    Epilepsia; 2019 Dec; 60(12):2359-2369. PubMed ID: 31758544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral cannabinoid receptor, CB2, regulates bone mass.
    Ofek O; Karsak M; Leclerc N; Fogel M; Frenkel B; Wright K; Tam J; Attar-Namdar M; Kram V; Shohami E; Mechoulam R; Zimmer A; Bab I
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):696-701. PubMed ID: 16407142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Cannabinoid CB2 Receptor Gene (CNR2) Polymorphism in Children with Immune Thrombocytopenic Purpura in Beni-Suef Governorate in Egypt.
    Ezzat DA; Hammam AA; El-Malah WM; Khattab RA; Mangoud EM
    Egypt J Immunol; 2017 Jan; 24(1):57-66. PubMed ID: 29120578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor.
    Marino S; Idris AI
    Pharmacol Res; 2017 May; 119():391-403. PubMed ID: 28274851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid CB2 receptors and hypersensitivity to methamphetamine: Vulnerability to schizophrenia.
    Canseco-Alba A; Tabata K; Momoki Y; Tabassum T; Horiuchi Y; Arinami T; Onaivi ES; Ishiguro H
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110924. PubMed ID: 38135096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CB2-deficiency is associated with a stronger hypertrophy and remodeling of the right ventricle in a murine model of left pulmonary artery occlusion.
    Duerr GD; Feißt A; Halbach K; Verfuerth L; Gestrich C; Wenzel D; Zimmer A; Breuer J; Dewald O
    Life Sci; 2018 Dec; 215():96-105. PubMed ID: 30403990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cannabinoid receptor type 2 (CNR2) gene is associated with hand bone strength phenotypes in an ethnically homogeneous family sample.
    Karsak M; Malkin I; Toliat MR; Kubisch C; Nürnberg P; Zimmer A; Livshits G
    Hum Genet; 2009 Nov; 126(5):629-36. PubMed ID: 19565271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of CD4
    Chen J; Wang F; Zhang S; Lin Q; Xu H; Zhu T; Peng L; Cen F; Li F; Wang Z; Feng CG; Yin Z; Liu Y; Zhang G
    J Immunol; 2022 Jun; 208(11):2515-2522. PubMed ID: 35534212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common polymorphisms in the cannabinoid CB2 receptor gene (CNR2) are not associated with myocardial infarction and cardiovascular risk factors.
    Reinhard W; Stark K; Neureuther K; Sedlacek K; Fischer M; Baessler A; Weber S; Kaess B; Wiedmann S; Erdmann J; Lieb W; Jeron A; Riegger G; Hengstenberg C
    Int J Mol Med; 2008 Aug; 22(2):165-74. PubMed ID: 18636169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.